Compare current Tesamorelin research listings for Canada.
This exact seller page states Canada market coverage. It is dated catalog observations, not proof of legal supply, contents, safety, or medical suitability.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
01
What does a search for Tesamorelin in Canada need to establish?
Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business. That record does not establish the status or identity of every tesamorelin listing, and it does not transfer the US EGRIFTA WR approval to a research vial.
02
Which official records should be checked for Tesamorelin in Canada?
Resolve the exact identity of Tesamorelin through Check the FDA Purple Book product record from U.S. Food and Drug Administration. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.
03
Does an online listing prove Tesamorelin is authorized or available in Canada?
No. A page using the name Tesamorelin, local currency, a domestic delivery claim, or a familiar package image is only a lead. This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
Continue the exact comparison
Related country and compound records.
Compare another tracked name in Canada, or keep Tesamorelin fixed and change the destination within North America. The identity, product, and seller checks remain separate.
Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business. That record does not establish the status or identity of every tesamorelin listing, and it does not transfer the US EGRIFTA WR approval to a research vial.
A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Check the FDA Purple Book product record
Check the FDA Purple Book product record is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.
Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist
Repeat the country checks before comparing any offer.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
01
Check the DIN
Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.
02
Verify the pharmacy
Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.
03
Separate research labels
Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.
Primary evidence
Audit every source used by this page.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.
Compare another tracked name in Canada, or keep Tesamorelin fixed and change the destination within North America. The identity, product, and seller checks remain separate.
